nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—ESR1—atherosclerosis	0.607	1	CbGaD
Etonogestrel—CYP3A4—Ezetimibe—atherosclerosis	0.0292	0.211	CbGbCtD
Etonogestrel—CYP3A4—Rosuvastatin—atherosclerosis	0.0292	0.211	CbGbCtD
Etonogestrel—CYP3A4—Simvastatin—atherosclerosis	0.0272	0.196	CbGbCtD
Etonogestrel—CYP3A4—Pravastatin—atherosclerosis	0.0266	0.192	CbGbCtD
Etonogestrel—CYP3A4—Lovastatin—atherosclerosis	0.0266	0.192	CbGbCtD
Etonogestrel—SHBG—hindlimb—atherosclerosis	0.00602	0.234	CbGeAlD
Etonogestrel—PGR—artery—atherosclerosis	0.00332	0.129	CbGeAlD
Etonogestrel—PGR—blood vessel—atherosclerosis	0.00259	0.101	CbGeAlD
Etonogestrel—ESR1—blood vessel—atherosclerosis	0.00203	0.0787	CbGeAlD
Etonogestrel—SHBG—connective tissue—atherosclerosis	0.00147	0.0572	CbGeAlD
Etonogestrel—PGR—connective tissue—atherosclerosis	0.00133	0.0516	CbGeAlD
Etonogestrel—SHBG—cardiovascular system—atherosclerosis	0.00128	0.0498	CbGeAlD
Etonogestrel—PGR—cardiovascular system—atherosclerosis	0.00116	0.0449	CbGeAlD
Etonogestrel—SHBG—adipose tissue—atherosclerosis	0.00113	0.0439	CbGeAlD
Etonogestrel—ESR1—connective tissue—atherosclerosis	0.00104	0.0403	CbGeAlD
Etonogestrel—PGR—adipose tissue—atherosclerosis	0.00102	0.0396	CbGeAlD
Etonogestrel—Danazol—CCL2—atherosclerosis	0.00096	0.159	CrCbGaD
Etonogestrel—Quinestrol—ESR1—atherosclerosis	0.000945	0.157	CrCbGaD
Etonogestrel—ESR1—cardiovascular system—atherosclerosis	0.000904	0.0351	CbGeAlD
Etonogestrel—ESR1—adipose tissue—atherosclerosis	0.000797	0.0309	CbGeAlD
Etonogestrel—SHBG—liver—atherosclerosis	0.000793	0.0308	CbGeAlD
Etonogestrel—Mestranol—ESR1—atherosclerosis	0.000716	0.119	CrCbGaD
Etonogestrel—Desogestrel—ESR1—atherosclerosis	0.000708	0.117	CrCbGaD
Etonogestrel—Norgestimate—ESR1—atherosclerosis	0.000662	0.11	CrCbGaD
Etonogestrel—Flatulence—Rosuvastatin—atherosclerosis	0.000634	0.00367	CcSEcCtD
Etonogestrel—Dysuria—Pravastatin—atherosclerosis	0.000619	0.00358	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000616	0.00356	CcSEcCtD
Etonogestrel—Sinusitis—Simvastatin—atherosclerosis	0.000613	0.00354	CcSEcCtD
Etonogestrel—Pharyngitis—Ezetimibe—atherosclerosis	0.00061	0.00353	CcSEcCtD
Etonogestrel—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000604	0.0035	CcSEcCtD
Etonogestrel—Weight increased—Pravastatin—atherosclerosis	0.000603	0.00349	CcSEcCtD
Etonogestrel—Weight decreased—Pravastatin—atherosclerosis	0.000599	0.00347	CcSEcCtD
Etonogestrel—Depression—Pravastatin—atherosclerosis	0.000589	0.00341	CcSEcCtD
Etonogestrel—Angioedema—Rosuvastatin—atherosclerosis	0.000588	0.0034	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000579	0.00335	CcSEcCtD
Etonogestrel—Urinary tract infection—Pravastatin—atherosclerosis	0.000574	0.00332	CcSEcCtD
Etonogestrel—Cough—Rosuvastatin—atherosclerosis	0.000562	0.00325	CcSEcCtD
Etonogestrel—ESR1—liver—atherosclerosis	0.000559	0.0217	CbGeAlD
Etonogestrel—Angiopathy—Ezetimibe—atherosclerosis	0.000558	0.00323	CcSEcCtD
Etonogestrel—Immune system disorder—Ezetimibe—atherosclerosis	0.000555	0.00321	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—ESR2—atherosclerosis	0.000554	0.092	CrCbGaD
Etonogestrel—Sinusitis—Pravastatin—atherosclerosis	0.000554	0.0032	CcSEcCtD
Etonogestrel—Alopecia—Lovastatin—atherosclerosis	0.000554	0.0032	CcSEcCtD
Etonogestrel—Arthralgia—Rosuvastatin—atherosclerosis	0.000548	0.00317	CcSEcCtD
Etonogestrel—Myalgia—Rosuvastatin—atherosclerosis	0.000548	0.00317	CcSEcCtD
Etonogestrel—Alopecia—Ezetimibe—atherosclerosis	0.000543	0.00314	CcSEcCtD
Etonogestrel—Haemoglobin—Niacin—atherosclerosis	0.000541	0.00313	CcSEcCtD
Etonogestrel—Rhinitis—Niacin—atherosclerosis	0.00054	0.00312	CcSEcCtD
Etonogestrel—Mental disorder—Ezetimibe—atherosclerosis	0.000539	0.00312	CcSEcCtD
Etonogestrel—Haemorrhage—Niacin—atherosclerosis	0.000538	0.00311	CcSEcCtD
Etonogestrel—Flatulence—Lovastatin—atherosclerosis	0.000538	0.00311	CcSEcCtD
Etonogestrel—Hypoaesthesia—Niacin—atherosclerosis	0.000536	0.0031	CcSEcCtD
Etonogestrel—Malnutrition—Ezetimibe—atherosclerosis	0.000535	0.0031	CcSEcCtD
Etonogestrel—Erythema—Ezetimibe—atherosclerosis	0.000535	0.0031	CcSEcCtD
Etonogestrel—Rhinitis—Pravastatin—atherosclerosis	0.000531	0.00307	CcSEcCtD
Etonogestrel—Back pain—Lovastatin—atherosclerosis	0.000528	0.00305	CcSEcCtD
Etonogestrel—Hypoaesthesia—Pravastatin—atherosclerosis	0.000527	0.00305	CcSEcCtD
Etonogestrel—Flatulence—Ezetimibe—atherosclerosis	0.000527	0.00305	CcSEcCtD
Etonogestrel—Pharyngitis—Pravastatin—atherosclerosis	0.000526	0.00304	CcSEcCtD
Etonogestrel—Muscle spasms—Lovastatin—atherosclerosis	0.000525	0.00304	CcSEcCtD
Etonogestrel—Infection—Rosuvastatin—atherosclerosis	0.000522	0.00302	CcSEcCtD
Etonogestrel—Visual impairment—Niacin—atherosclerosis	0.000519	0.003	CcSEcCtD
Etonogestrel—Alopecia—Simvastatin—atherosclerosis	0.000518	0.003	CcSEcCtD
Etonogestrel—Back pain—Ezetimibe—atherosclerosis	0.000518	0.003	CcSEcCtD
Etonogestrel—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000515	0.00298	CcSEcCtD
Etonogestrel—Muscle spasms—Ezetimibe—atherosclerosis	0.000515	0.00298	CcSEcCtD
Etonogestrel—Mental disorder—Simvastatin—atherosclerosis	0.000514	0.00297	CcSEcCtD
Etonogestrel—Visual impairment—Pravastatin—atherosclerosis	0.000511	0.00296	CcSEcCtD
Etonogestrel—Erythema—Simvastatin—atherosclerosis	0.00051	0.00295	CcSEcCtD
Etonogestrel—Ill-defined disorder—Lovastatin—atherosclerosis	0.000506	0.00293	CcSEcCtD
Etonogestrel—Eye disorder—Niacin—atherosclerosis	0.000503	0.00291	CcSEcCtD
Etonogestrel—Flatulence—Simvastatin—atherosclerosis	0.000503	0.00291	CcSEcCtD
Etonogestrel—Angioedema—Lovastatin—atherosclerosis	0.000499	0.00288	CcSEcCtD
Etonogestrel—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000497	0.00287	CcSEcCtD
Etonogestrel—Malaise—Lovastatin—atherosclerosis	0.000492	0.00285	CcSEcCtD
Etonogestrel—Muscle spasms—Simvastatin—atherosclerosis	0.000491	0.00284	CcSEcCtD
Etonogestrel—Angioedema—Ezetimibe—atherosclerosis	0.000489	0.00283	CcSEcCtD
Etonogestrel—Angiopathy—Niacin—atherosclerosis	0.000488	0.00283	CcSEcCtD
Etonogestrel—Malaise—Ezetimibe—atherosclerosis	0.000483	0.00279	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000479	0.00277	CcSEcCtD
Etonogestrel—Alopecia—Niacin—atherosclerosis	0.000476	0.00275	CcSEcCtD
Etonogestrel—Insomnia—Rosuvastatin—atherosclerosis	0.000475	0.00275	CcSEcCtD
Etonogestrel—Ill-defined disorder—Simvastatin—atherosclerosis	0.000474	0.00274	CcSEcCtD
Etonogestrel—Paraesthesia—Rosuvastatin—atherosclerosis	0.000472	0.00273	CcSEcCtD
Etonogestrel—Erythema—Niacin—atherosclerosis	0.000469	0.00271	CcSEcCtD
Etonogestrel—Malnutrition—Niacin—atherosclerosis	0.000469	0.00271	CcSEcCtD
Etonogestrel—Alopecia—Pravastatin—atherosclerosis	0.000468	0.00271	CcSEcCtD
Etonogestrel—Cough—Ezetimibe—atherosclerosis	0.000467	0.0027	CcSEcCtD
Etonogestrel—Angioedema—Simvastatin—atherosclerosis	0.000466	0.0027	CcSEcCtD
Etonogestrel—Arthralgia—Lovastatin—atherosclerosis	0.000465	0.00269	CcSEcCtD
Etonogestrel—Myalgia—Lovastatin—atherosclerosis	0.000465	0.00269	CcSEcCtD
Etonogestrel—Anxiety—Lovastatin—atherosclerosis	0.000463	0.00268	CcSEcCtD
Etonogestrel—Dyspepsia—Rosuvastatin—atherosclerosis	0.000463	0.00268	CcSEcCtD
Etonogestrel—Hypertension—Ezetimibe—atherosclerosis	0.000462	0.00267	CcSEcCtD
Etonogestrel—Flatulence—Niacin—atherosclerosis	0.000462	0.00267	CcSEcCtD
Etonogestrel—Malaise—Simvastatin—atherosclerosis	0.00046	0.00266	CcSEcCtD
Etonogestrel—Tension—Niacin—atherosclerosis	0.00046	0.00266	CcSEcCtD
Etonogestrel—Discomfort—Lovastatin—atherosclerosis	0.000459	0.00266	CcSEcCtD
Etonogestrel—Arthralgia—Ezetimibe—atherosclerosis	0.000456	0.00264	CcSEcCtD
Etonogestrel—Myalgia—Ezetimibe—atherosclerosis	0.000456	0.00264	CcSEcCtD
Etonogestrel—Nervousness—Niacin—atherosclerosis	0.000455	0.00263	CcSEcCtD
Etonogestrel—Flatulence—Pravastatin—atherosclerosis	0.000455	0.00263	CcSEcCtD
Etonogestrel—Tension—Pravastatin—atherosclerosis	0.000453	0.00262	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000453	0.00262	CcSEcCtD
Etonogestrel—Muscle spasms—Niacin—atherosclerosis	0.000451	0.00261	CcSEcCtD
Etonogestrel—Discomfort—Ezetimibe—atherosclerosis	0.00045	0.0026	CcSEcCtD
Etonogestrel—Pain—Rosuvastatin—atherosclerosis	0.000449	0.0026	CcSEcCtD
Etonogestrel—Constipation—Rosuvastatin—atherosclerosis	0.000449	0.0026	CcSEcCtD
Etonogestrel—Nervousness—Pravastatin—atherosclerosis	0.000448	0.00259	CcSEcCtD
Etonogestrel—Anaphylactic shock—Lovastatin—atherosclerosis	0.000445	0.00258	CcSEcCtD
Etonogestrel—Muscle spasms—Pravastatin—atherosclerosis	0.000444	0.00257	CcSEcCtD
Etonogestrel—Infection—Lovastatin—atherosclerosis	0.000442	0.00256	CcSEcCtD
Etonogestrel—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000437	0.00253	CcSEcCtD
Etonogestrel—Arthralgia—Simvastatin—atherosclerosis	0.000435	0.00251	CcSEcCtD
Etonogestrel—Myalgia—Simvastatin—atherosclerosis	0.000435	0.00251	CcSEcCtD
Etonogestrel—Infection—Ezetimibe—atherosclerosis	0.000434	0.00251	CcSEcCtD
Etonogestrel—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000433	0.00251	CcSEcCtD
Etonogestrel—Anxiety—Simvastatin—atherosclerosis	0.000433	0.00251	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00043	0.00249	CcSEcCtD
Etonogestrel—Discomfort—Simvastatin—atherosclerosis	0.000429	0.00248	CcSEcCtD
Etonogestrel—Nervous system disorder—Ezetimibe—atherosclerosis	0.000428	0.00248	CcSEcCtD
Etonogestrel—Angioedema—Niacin—atherosclerosis	0.000428	0.00248	CcSEcCtD
Etonogestrel—Ill-defined disorder—Pravastatin—atherosclerosis	0.000428	0.00248	CcSEcCtD
Etonogestrel—Anorexia—Lovastatin—atherosclerosis	0.000425	0.00246	CcSEcCtD
Etonogestrel—Skin disorder—Ezetimibe—atherosclerosis	0.000424	0.00245	CcSEcCtD
Etonogestrel—Angioedema—Pravastatin—atherosclerosis	0.000422	0.00244	CcSEcCtD
Etonogestrel—Urticaria—Rosuvastatin—atherosclerosis	0.000417	0.00242	CcSEcCtD
Etonogestrel—Oedema—Simvastatin—atherosclerosis	0.000417	0.00241	CcSEcCtD
Etonogestrel—Anaphylactic shock—Simvastatin—atherosclerosis	0.000417	0.00241	CcSEcCtD
Etonogestrel—Malaise—Pravastatin—atherosclerosis	0.000416	0.00241	CcSEcCtD
Etonogestrel—Abdominal pain—Rosuvastatin—atherosclerosis	0.000415	0.0024	CcSEcCtD
Etonogestrel—Infection—Simvastatin—atherosclerosis	0.000414	0.00239	CcSEcCtD
Etonogestrel—Cough—Niacin—atherosclerosis	0.000409	0.00237	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000406	0.00235	CcSEcCtD
Etonogestrel—Levonorgestrel—ESR1—atherosclerosis	0.000405	0.0672	CrCbGaD
Etonogestrel—Insomnia—Lovastatin—atherosclerosis	0.000403	0.00233	CcSEcCtD
Etonogestrel—Cough—Pravastatin—atherosclerosis	0.000403	0.00233	CcSEcCtD
Etonogestrel—Paraesthesia—Lovastatin—atherosclerosis	0.0004	0.00231	CcSEcCtD
Etonogestrel—Myalgia—Niacin—atherosclerosis	0.000399	0.00231	CcSEcCtD
Etonogestrel—Arthralgia—Niacin—atherosclerosis	0.000399	0.00231	CcSEcCtD
Etonogestrel—Hypertension—Pravastatin—atherosclerosis	0.000398	0.0023	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000398	0.0023	CcSEcCtD
Etonogestrel—Anorexia—Simvastatin—atherosclerosis	0.000397	0.0023	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000396	0.00229	CcSEcCtD
Etonogestrel—Insomnia—Ezetimibe—atherosclerosis	0.000395	0.00229	CcSEcCtD
Etonogestrel—Arthralgia—Pravastatin—atherosclerosis	0.000393	0.00227	CcSEcCtD
Etonogestrel—Myalgia—Pravastatin—atherosclerosis	0.000393	0.00227	CcSEcCtD
Etonogestrel—Paraesthesia—Ezetimibe—atherosclerosis	0.000392	0.00227	CcSEcCtD
Etonogestrel—Dyspepsia—Lovastatin—atherosclerosis	0.000392	0.00227	CcSEcCtD
Etonogestrel—Anxiety—Pravastatin—atherosclerosis	0.000391	0.00226	CcSEcCtD
Etonogestrel—Discomfort—Pravastatin—atherosclerosis	0.000388	0.00225	CcSEcCtD
Etonogestrel—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000387	0.00224	CcSEcCtD
Etonogestrel—Decreased appetite—Lovastatin—atherosclerosis	0.000387	0.00224	CcSEcCtD
Etonogestrel—Dyspepsia—Ezetimibe—atherosclerosis	0.000385	0.00222	CcSEcCtD
Etonogestrel—Fatigue—Lovastatin—atherosclerosis	0.000384	0.00222	CcSEcCtD
Etonogestrel—Anaphylactic shock—Niacin—atherosclerosis	0.000382	0.00221	CcSEcCtD
Etonogestrel—Oedema—Niacin—atherosclerosis	0.000382	0.00221	CcSEcCtD
Etonogestrel—Pain—Lovastatin—atherosclerosis	0.000381	0.0022	CcSEcCtD
Etonogestrel—Constipation—Lovastatin—atherosclerosis	0.000381	0.0022	CcSEcCtD
Etonogestrel—Decreased appetite—Ezetimibe—atherosclerosis	0.00038	0.0022	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00038	0.0022	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000377	0.00218	CcSEcCtD
Etonogestrel—Asthenia—Rosuvastatin—atherosclerosis	0.000377	0.00218	CcSEcCtD
Etonogestrel—Insomnia—Simvastatin—atherosclerosis	0.000377	0.00218	CcSEcCtD
Etonogestrel—Anaphylactic shock—Pravastatin—atherosclerosis	0.000377	0.00218	CcSEcCtD
Etonogestrel—Oedema—Pravastatin—atherosclerosis	0.000377	0.00218	CcSEcCtD
Etonogestrel—Fatigue—Ezetimibe—atherosclerosis	0.000377	0.00218	CcSEcCtD
Etonogestrel—Infection—Pravastatin—atherosclerosis	0.000374	0.00216	CcSEcCtD
Etonogestrel—Paraesthesia—Simvastatin—atherosclerosis	0.000374	0.00216	CcSEcCtD
Etonogestrel—Pain—Ezetimibe—atherosclerosis	0.000374	0.00216	CcSEcCtD
Etonogestrel—Constipation—Ezetimibe—atherosclerosis	0.000374	0.00216	CcSEcCtD
Etonogestrel—Pruritus—Rosuvastatin—atherosclerosis	0.000372	0.00215	CcSEcCtD
Etonogestrel—Skin disorder—Niacin—atherosclerosis	0.000372	0.00215	CcSEcCtD
Etonogestrel—Danazol—ESR1—atherosclerosis	0.000369	0.0612	CrCbGaD
Etonogestrel—Feeling abnormal—Lovastatin—atherosclerosis	0.000367	0.00212	CcSEcCtD
Etonogestrel—Dyspepsia—Simvastatin—atherosclerosis	0.000367	0.00212	CcSEcCtD
Etonogestrel—Anorexia—Niacin—atherosclerosis	0.000365	0.00211	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000364	0.00211	CcSEcCtD
Etonogestrel—Decreased appetite—Simvastatin—atherosclerosis	0.000362	0.00209	CcSEcCtD
Etonogestrel—Feeling abnormal—Ezetimibe—atherosclerosis	0.00036	0.00208	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00036	0.00208	CcSEcCtD
Etonogestrel—Diarrhoea—Rosuvastatin—atherosclerosis	0.00036	0.00208	CcSEcCtD
Etonogestrel—Fatigue—Simvastatin—atherosclerosis	0.000359	0.00208	CcSEcCtD
Etonogestrel—Anorexia—Pravastatin—atherosclerosis	0.000359	0.00208	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000357	0.00207	CcSEcCtD
Etonogestrel—Constipation—Simvastatin—atherosclerosis	0.000356	0.00206	CcSEcCtD
Etonogestrel—Pain—Simvastatin—atherosclerosis	0.000356	0.00206	CcSEcCtD
Etonogestrel—Urticaria—Lovastatin—atherosclerosis	0.000354	0.00205	CcSEcCtD
Etonogestrel—Abdominal pain—Lovastatin—atherosclerosis	0.000352	0.00204	CcSEcCtD
Etonogestrel—Body temperature increased—Lovastatin—atherosclerosis	0.000352	0.00204	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000348	0.00202	CcSEcCtD
Etonogestrel—Dizziness—Rosuvastatin—atherosclerosis	0.000348	0.00201	CcSEcCtD
Etonogestrel—Urticaria—Ezetimibe—atherosclerosis	0.000347	0.00201	CcSEcCtD
Etonogestrel—Insomnia—Niacin—atherosclerosis	0.000346	0.002	CcSEcCtD
Etonogestrel—Body temperature increased—Ezetimibe—atherosclerosis	0.000345	0.002	CcSEcCtD
Etonogestrel—Abdominal pain—Ezetimibe—atherosclerosis	0.000345	0.002	CcSEcCtD
Etonogestrel—Paraesthesia—Niacin—atherosclerosis	0.000343	0.00199	CcSEcCtD
Etonogestrel—Feeling abnormal—Simvastatin—atherosclerosis	0.000343	0.00199	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000343	0.00198	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—ESR1—atherosclerosis	0.000341	0.0567	CrCbGaD
Etonogestrel—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000341	0.00197	CcSEcCtD
Etonogestrel—Insomnia—Pravastatin—atherosclerosis	0.000341	0.00197	CcSEcCtD
Etonogestrel—Somnolence—Niacin—atherosclerosis	0.00034	0.00197	CcSEcCtD
Etonogestrel—Paraesthesia—Pravastatin—atherosclerosis	0.000338	0.00196	CcSEcCtD
Etonogestrel—Dyspepsia—Niacin—atherosclerosis	0.000337	0.00195	CcSEcCtD
Etonogestrel—Decreased appetite—Niacin—atherosclerosis	0.000332	0.00192	CcSEcCtD
Etonogestrel—Dyspepsia—Pravastatin—atherosclerosis	0.000332	0.00192	CcSEcCtD
Etonogestrel—Rash—Rosuvastatin—atherosclerosis	0.000331	0.00192	CcSEcCtD
Etonogestrel—Dermatitis—Rosuvastatin—atherosclerosis	0.000331	0.00192	CcSEcCtD
Etonogestrel—Urticaria—Simvastatin—atherosclerosis	0.000331	0.00191	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Niacin—atherosclerosis	0.00033	0.00191	CcSEcCtD
Etonogestrel—Body temperature increased—Simvastatin—atherosclerosis	0.000329	0.00191	CcSEcCtD
Etonogestrel—Abdominal pain—Simvastatin—atherosclerosis	0.000329	0.00191	CcSEcCtD
Etonogestrel—Headache—Rosuvastatin—atherosclerosis	0.000329	0.0019	CcSEcCtD
Etonogestrel—Hypersensitivity—Lovastatin—atherosclerosis	0.000328	0.0019	CcSEcCtD
Etonogestrel—Decreased appetite—Pravastatin—atherosclerosis	0.000327	0.00189	CcSEcCtD
Etonogestrel—Pain—Niacin—atherosclerosis	0.000327	0.00189	CcSEcCtD
Etonogestrel—Fatigue—Pravastatin—atherosclerosis	0.000325	0.00188	CcSEcCtD
Etonogestrel—Pain—Pravastatin—atherosclerosis	0.000322	0.00186	CcSEcCtD
Etonogestrel—Constipation—Pravastatin—atherosclerosis	0.000322	0.00186	CcSEcCtD
Etonogestrel—Hypersensitivity—Ezetimibe—atherosclerosis	0.000322	0.00186	CcSEcCtD
Etonogestrel—Asthenia—Lovastatin—atherosclerosis	0.00032	0.00185	CcSEcCtD
Etonogestrel—Pruritus—Lovastatin—atherosclerosis	0.000315	0.00182	CcSEcCtD
Etonogestrel—Asthenia—Ezetimibe—atherosclerosis	0.000313	0.00181	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Niacin—atherosclerosis	0.000313	0.00181	CcSEcCtD
Etonogestrel—Nausea—Rosuvastatin—atherosclerosis	0.000312	0.00181	CcSEcCtD
Etonogestrel—CYP3A4—liver—atherosclerosis	0.000312	0.0121	CbGeAlD
Etonogestrel—Feeling abnormal—Pravastatin—atherosclerosis	0.00031	0.0018	CcSEcCtD
Etonogestrel—Pruritus—Ezetimibe—atherosclerosis	0.000309	0.00179	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000308	0.00178	CcSEcCtD
Etonogestrel—Hypersensitivity—Simvastatin—atherosclerosis	0.000307	0.00178	CcSEcCtD
Etonogestrel—Diarrhoea—Lovastatin—atherosclerosis	0.000305	0.00176	CcSEcCtD
Etonogestrel—Urticaria—Niacin—atherosclerosis	0.000304	0.00176	CcSEcCtD
Etonogestrel—Abdominal pain—Niacin—atherosclerosis	0.000302	0.00175	CcSEcCtD
Etonogestrel—Body temperature increased—Niacin—atherosclerosis	0.000302	0.00175	CcSEcCtD
Etonogestrel—Urticaria—Pravastatin—atherosclerosis	0.000299	0.00173	CcSEcCtD
Etonogestrel—Asthenia—Simvastatin—atherosclerosis	0.000299	0.00173	CcSEcCtD
Etonogestrel—Diarrhoea—Ezetimibe—atherosclerosis	0.000299	0.00173	CcSEcCtD
Etonogestrel—Abdominal pain—Pravastatin—atherosclerosis	0.000298	0.00172	CcSEcCtD
Etonogestrel—Body temperature increased—Pravastatin—atherosclerosis	0.000298	0.00172	CcSEcCtD
Etonogestrel—Pruritus—Simvastatin—atherosclerosis	0.000295	0.0017	CcSEcCtD
Etonogestrel—Dizziness—Lovastatin—atherosclerosis	0.000294	0.0017	CcSEcCtD
Etonogestrel—Dizziness—Ezetimibe—atherosclerosis	0.000289	0.00167	CcSEcCtD
Etonogestrel—Diarrhoea—Simvastatin—atherosclerosis	0.000285	0.00165	CcSEcCtD
Etonogestrel—Vomiting—Lovastatin—atherosclerosis	0.000283	0.00164	CcSEcCtD
Etonogestrel—Hypersensitivity—Niacin—atherosclerosis	0.000282	0.00163	CcSEcCtD
Etonogestrel—Rash—Lovastatin—atherosclerosis	0.000281	0.00162	CcSEcCtD
Etonogestrel—Dermatitis—Lovastatin—atherosclerosis	0.000281	0.00162	CcSEcCtD
Etonogestrel—Headache—Lovastatin—atherosclerosis	0.000279	0.00161	CcSEcCtD
Etonogestrel—Vomiting—Ezetimibe—atherosclerosis	0.000278	0.00161	CcSEcCtD
Etonogestrel—Hypersensitivity—Pravastatin—atherosclerosis	0.000277	0.00161	CcSEcCtD
Etonogestrel—Dizziness—Simvastatin—atherosclerosis	0.000275	0.00159	CcSEcCtD
Etonogestrel—Rash—Ezetimibe—atherosclerosis	0.000275	0.00159	CcSEcCtD
Etonogestrel—Dermatitis—Ezetimibe—atherosclerosis	0.000275	0.00159	CcSEcCtD
Etonogestrel—Asthenia—Niacin—atherosclerosis	0.000274	0.00159	CcSEcCtD
Etonogestrel—Headache—Ezetimibe—atherosclerosis	0.000274	0.00158	CcSEcCtD
Etonogestrel—Pruritus—Niacin—atherosclerosis	0.000271	0.00157	CcSEcCtD
Etonogestrel—Asthenia—Pravastatin—atherosclerosis	0.00027	0.00156	CcSEcCtD
Etonogestrel—Pruritus—Pravastatin—atherosclerosis	0.000266	0.00154	CcSEcCtD
Etonogestrel—Vomiting—Simvastatin—atherosclerosis	0.000265	0.00153	CcSEcCtD
Etonogestrel—Nausea—Lovastatin—atherosclerosis	0.000265	0.00153	CcSEcCtD
Etonogestrel—Rash—Simvastatin—atherosclerosis	0.000263	0.00152	CcSEcCtD
Etonogestrel—Dermatitis—Simvastatin—atherosclerosis	0.000262	0.00152	CcSEcCtD
Etonogestrel—Diarrhoea—Niacin—atherosclerosis	0.000262	0.00151	CcSEcCtD
Etonogestrel—Headache—Simvastatin—atherosclerosis	0.000261	0.00151	CcSEcCtD
Etonogestrel—Nausea—Ezetimibe—atherosclerosis	0.000259	0.0015	CcSEcCtD
Etonogestrel—Diarrhoea—Pravastatin—atherosclerosis	0.000258	0.00149	CcSEcCtD
Etonogestrel—Dizziness—Niacin—atherosclerosis	0.000253	0.00146	CcSEcCtD
Etonogestrel—Dizziness—Pravastatin—atherosclerosis	0.000249	0.00144	CcSEcCtD
Etonogestrel—Nausea—Simvastatin—atherosclerosis	0.000247	0.00143	CcSEcCtD
Etonogestrel—Vomiting—Niacin—atherosclerosis	0.000243	0.00141	CcSEcCtD
Etonogestrel—Rash—Niacin—atherosclerosis	0.000241	0.0014	CcSEcCtD
Etonogestrel—Dermatitis—Niacin—atherosclerosis	0.000241	0.00139	CcSEcCtD
Etonogestrel—Headache—Niacin—atherosclerosis	0.00024	0.00139	CcSEcCtD
Etonogestrel—Vomiting—Pravastatin—atherosclerosis	0.000239	0.00139	CcSEcCtD
Etonogestrel—Rash—Pravastatin—atherosclerosis	0.000237	0.00137	CcSEcCtD
Etonogestrel—Dermatitis—Pravastatin—atherosclerosis	0.000237	0.00137	CcSEcCtD
Etonogestrel—Headache—Pravastatin—atherosclerosis	0.000236	0.00136	CcSEcCtD
Etonogestrel—Nausea—Niacin—atherosclerosis	0.000227	0.00131	CcSEcCtD
Etonogestrel—Nausea—Pravastatin—atherosclerosis	0.000224	0.00129	CcSEcCtD
Etonogestrel—ESR1—Estrogen signaling pathway—AKT1—atherosclerosis	0.000157	0.00316	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000156	0.00314	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—IFNG—atherosclerosis	0.000154	0.00309	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000153	0.00307	CbGpPWpGaD
Etonogestrel—Norethindrone—ALB—atherosclerosis	0.000146	0.0243	CrCbGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CXCL8—atherosclerosis	0.000143	0.00287	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000142	0.00285	CbGpPWpGaD
Etonogestrel—Methyltestosterone—ALB—atherosclerosis	0.000139	0.023	CrCbGaD
Etonogestrel—ESR1—Regulation of Telomerase—IFNG—atherosclerosis	0.000137	0.00276	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000134	0.00269	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—NOS3—atherosclerosis	0.000133	0.00267	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000132	0.00266	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000131	0.00263	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.000129	0.00258	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—MAPK8—atherosclerosis	0.000126	0.00253	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000125	0.00251	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000121	0.00244	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—PARP1—atherosclerosis	0.000118	0.00238	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000115	0.00231	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—NFKB1—atherosclerosis	0.000114	0.0023	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—IL1B—atherosclerosis	0.000113	0.00227	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000113	0.00227	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—ESR2—atherosclerosis	0.000112	0.00225	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—MAPK3—atherosclerosis	0.00011	0.00221	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000107	0.00214	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—NFKB1—atherosclerosis	0.000106	0.00212	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PDGFB—atherosclerosis	0.000105	0.00212	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000105	0.00211	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK8—atherosclerosis	0.000104	0.00209	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—atherosclerosis	9.91e-05	0.00199	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MAPK3—atherosclerosis	9.8e-05	0.00197	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—TGFB1—atherosclerosis	9.51e-05	0.00191	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	9.49e-05	0.00191	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	9.49e-05	0.00191	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—STAT3—atherosclerosis	9.48e-05	0.00191	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TGFB1—atherosclerosis	9.29e-05	0.00187	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK3—atherosclerosis	9.06e-05	0.00182	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—MAPK3—atherosclerosis	8.77e-05	0.00176	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	8.77e-05	0.00176	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	8.65e-05	0.00174	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRH1—atherosclerosis	8.5e-05	0.00171	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	8.1e-05	0.00163	CbGpPWpGaD
Etonogestrel—Testosterone—ALB—atherosclerosis	8.05e-05	0.0134	CrCbGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—IL6—atherosclerosis	8.03e-05	0.00161	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	7.99e-05	0.00161	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—PPARA—atherosclerosis	7.49e-05	0.00151	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL6—atherosclerosis	7e-05	0.00141	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	6.94e-05	0.0014	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PARP1—atherosclerosis	6.94e-05	0.00139	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—ESR1—atherosclerosis	6.79e-05	0.00136	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOA4—atherosclerosis	6.67e-05	0.00134	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—AKT1—atherosclerosis	6.61e-05	0.00133	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—ESR2—atherosclerosis	6.57e-05	0.00132	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IL6—atherosclerosis	6.41e-05	0.00129	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HSPA1B—atherosclerosis	6.38e-05	0.00128	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—PPARG—atherosclerosis	6.19e-05	0.00125	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL4—atherosclerosis	6.15e-05	0.00124	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—AKT1—atherosclerosis	6.11e-05	0.00123	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	6.03e-05	0.00121	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—AKT1—atherosclerosis	5.92e-05	0.00119	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	5.76e-05	0.00116	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	5.75e-05	0.00116	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOA2—atherosclerosis	5.74e-05	0.00115	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PARP1—atherosclerosis	5.69e-05	0.00114	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—SERPINE1—atherosclerosis	5.58e-05	0.00112	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—UTS2—atherosclerosis	5.48e-05	0.0011	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	5.47e-05	0.0011	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR2—atherosclerosis	5.39e-05	0.00108	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CX3CR1—atherosclerosis	5.25e-05	0.00106	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASR—atherosclerosis	5.25e-05	0.00106	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CX3CL1—atherosclerosis	5.15e-05	0.00104	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MAPK3—atherosclerosis	5.15e-05	0.00104	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5e-05	0.001	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRH1—atherosclerosis	4.99e-05	0.001	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	4.91e-05	0.000987	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CNR2—atherosclerosis	4.88e-05	0.000982	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.53e-05	0.000912	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARA—atherosclerosis	4.4e-05	0.000884	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VWF—atherosclerosis	4.35e-05	0.000875	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SIRT1—atherosclerosis	4.34e-05	0.000873	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOC3—atherosclerosis	4.32e-05	0.00087	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LDLR—atherosclerosis	4.3e-05	0.000864	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.29e-05	0.000862	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL3—atherosclerosis	4.2e-05	0.000844	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.16e-05	0.000837	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NCF1—atherosclerosis	4.02e-05	0.000808	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOA4—atherosclerosis	3.91e-05	0.000787	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.89e-05	0.000781	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDNRA—atherosclerosis	3.8e-05	0.000763	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCR2—atherosclerosis	3.8e-05	0.000763	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CYBA—atherosclerosis	3.78e-05	0.00076	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—atherosclerosis	3.76e-05	0.000757	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HSPA1B—atherosclerosis	3.75e-05	0.000753	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PARP1—atherosclerosis	3.7e-05	0.000744	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GHRL—atherosclerosis	3.7e-05	0.000744	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PLAT—atherosclerosis	3.7e-05	0.000744	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—atherosclerosis	3.63e-05	0.000731	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.62e-05	0.000728	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARA—atherosclerosis	3.61e-05	0.000725	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL4—atherosclerosis	3.61e-05	0.000725	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.57e-05	0.000718	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	3.49e-05	0.000702	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—atherosclerosis	3.47e-05	0.000698	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOA2—atherosclerosis	3.37e-05	0.000678	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PARP1—atherosclerosis	3.34e-05	0.000672	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—SERPINE1—atherosclerosis	3.27e-05	0.000658	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR1—atherosclerosis	3.27e-05	0.000657	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KNG1—atherosclerosis	3.25e-05	0.000653	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AGTR1—atherosclerosis	3.23e-05	0.000649	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—UTS2—atherosclerosis	3.21e-05	0.000646	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ESR2—atherosclerosis	3.16e-05	0.000636	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PLG—atherosclerosis	3.15e-05	0.000633	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CX3CR1—atherosclerosis	3.08e-05	0.00062	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASR—atherosclerosis	3.08e-05	0.00062	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CX3CL1—atherosclerosis	3.02e-05	0.000608	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—atherosclerosis	2.98e-05	0.0006	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SOCS3—atherosclerosis	2.98e-05	0.000599	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.89e-05	0.000582	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP3—atherosclerosis	2.88e-05	0.000579	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CNR2—atherosclerosis	2.87e-05	0.000576	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF2—atherosclerosis	2.86e-05	0.000576	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOB—atherosclerosis	2.78e-05	0.000559	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDN1—atherosclerosis	2.74e-05	0.00055	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL5—atherosclerosis	2.72e-05	0.000546	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SERPINE1—atherosclerosis	2.69e-05	0.00054	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LPL—atherosclerosis	2.66e-05	0.000534	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PRKCG—atherosclerosis	2.58e-05	0.000519	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.57e-05	0.000516	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VWF—atherosclerosis	2.55e-05	0.000514	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SIRT1—atherosclerosis	2.55e-05	0.000512	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOC3—atherosclerosis	2.54e-05	0.00051	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LDLR—atherosclerosis	2.52e-05	0.000507	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SPP1—atherosclerosis	2.52e-05	0.000506	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL3—atherosclerosis	2.46e-05	0.000495	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLTP—atherosclerosis	2.41e-05	0.000485	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NCF1—atherosclerosis	2.36e-05	0.000474	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFB—atherosclerosis	2.33e-05	0.000468	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AGT—atherosclerosis	2.27e-05	0.000457	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCR2—atherosclerosis	2.23e-05	0.000448	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDNRA—atherosclerosis	2.23e-05	0.000448	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOE—atherosclerosis	2.23e-05	0.000448	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LEP—atherosclerosis	2.23e-05	0.000448	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CYBA—atherosclerosis	2.22e-05	0.000446	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CAV1—atherosclerosis	2.21e-05	0.000443	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOA1—atherosclerosis	2.2e-05	0.000442	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PLAT—atherosclerosis	2.17e-05	0.000437	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PARP1—atherosclerosis	2.17e-05	0.000437	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GHRL—atherosclerosis	2.17e-05	0.000437	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ESR1—atherosclerosis	2.13e-05	0.000427	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARA—atherosclerosis	2.12e-05	0.000426	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—F2—atherosclerosis	2.1e-05	0.000422	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.09e-05	0.000421	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.09e-05	0.000421	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CG—atherosclerosis	2.01e-05	0.000404	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KNG1—atherosclerosis	1.91e-05	0.000383	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INS—atherosclerosis	1.9e-05	0.000382	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AGTR1—atherosclerosis	1.89e-05	0.000381	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL2—atherosclerosis	1.87e-05	0.000376	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PLG—atherosclerosis	1.85e-05	0.000371	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1—atherosclerosis	1.84e-05	0.00037	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—atherosclerosis	1.75e-05	0.000352	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SOCS3—atherosclerosis	1.75e-05	0.000352	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MAPK3—atherosclerosis	1.75e-05	0.000351	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SERPINE1—atherosclerosis	1.75e-05	0.000351	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP3—atherosclerosis	1.69e-05	0.00034	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF2—atherosclerosis	1.68e-05	0.000338	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOS3—atherosclerosis	1.67e-05	0.000335	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.65e-05	0.000333	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOB—atherosclerosis	1.63e-05	0.000328	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDN1—atherosclerosis	1.61e-05	0.000323	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL5—atherosclerosis	1.59e-05	0.00032	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SERPINE1—atherosclerosis	1.58e-05	0.000317	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LPL—atherosclerosis	1.56e-05	0.000313	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—FABP4—atherosclerosis	1.55e-05	0.000313	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LCAT—atherosclerosis	1.55e-05	0.000313	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOA4—atherosclerosis	1.53e-05	0.000307	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRKCG—atherosclerosis	1.52e-05	0.000305	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.5e-05	0.000301	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL8—atherosclerosis	1.48e-05	0.000297	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPP1—atherosclerosis	1.48e-05	0.000297	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.39e-05	0.000279	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFB—atherosclerosis	1.37e-05	0.000275	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—atherosclerosis	1.34e-05	0.000269	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AGT—atherosclerosis	1.33e-05	0.000268	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NFKB1—atherosclerosis	1.32e-05	0.000266	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.31e-05	0.000264	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOA2—atherosclerosis	1.31e-05	0.000264	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.31e-05	0.000264	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.31e-05	0.000264	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LEP—atherosclerosis	1.31e-05	0.000263	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOE—atherosclerosis	1.31e-05	0.000263	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK8—atherosclerosis	1.3e-05	0.000262	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.3e-05	0.000261	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CAV1—atherosclerosis	1.29e-05	0.00026	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOA1—atherosclerosis	1.29e-05	0.00026	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LPA—atherosclerosis	1.25e-05	0.000252	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—F2—atherosclerosis	1.23e-05	0.000248	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BGN—atherosclerosis	1.21e-05	0.000244	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOA5—atherosclerosis	1.2e-05	0.000242	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—atherosclerosis	1.2e-05	0.000242	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—atherosclerosis	1.19e-05	0.000239	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	1.18e-05	0.000237	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—atherosclerosis	1.18e-05	0.000237	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.16e-05	0.000233	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK3—atherosclerosis	1.14e-05	0.000229	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.12e-05	0.000225	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INS—atherosclerosis	1.12e-05	0.000224	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—atherosclerosis	1.1e-05	0.000222	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL2—atherosclerosis	1.1e-05	0.000221	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1—atherosclerosis	1.08e-05	0.000217	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MAPK3—atherosclerosis	1.03e-05	0.000206	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	1.03e-05	0.000206	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NAMPT—atherosclerosis	1e-05	0.000201	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LIPC—atherosclerosis	9.96e-06	0.0002	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOC3—atherosclerosis	9.89e-06	0.000199	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LDLR—atherosclerosis	9.83e-06	0.000198	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOS3—atherosclerosis	9.79e-06	0.000197	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CETP—atherosclerosis	9.61e-06	0.000193	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.2e-06	0.000185	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.69e-06	0.000175	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL8—atherosclerosis	8.68e-06	0.000175	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—atherosclerosis	8.31e-06	0.000167	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—atherosclerosis	7.85e-06	0.000158	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NFKB1—atherosclerosis	7.77e-06	0.000156	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.74e-06	0.000156	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—atherosclerosis	7.67e-06	0.000154	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK8—atherosclerosis	7.64e-06	0.000154	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—atherosclerosis	7.05e-06	0.000142	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—atherosclerosis	6.98e-06	0.00014	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—atherosclerosis	6.92e-06	0.000139	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK3—atherosclerosis	6.67e-06	0.000134	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.64e-06	0.000134	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—atherosclerosis	6.47e-06	0.00013	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOB—atherosclerosis	6.36e-06	0.000128	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.19e-06	0.000124	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LPL—atherosclerosis	6.08e-06	0.000122	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPX1—atherosclerosis	5.93e-06	0.000119	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CD36—atherosclerosis	5.77e-06	0.000116	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.47e-06	0.00011	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARA—atherosclerosis	5.37e-06	0.000108	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AGT—atherosclerosis	5.2e-06	0.000105	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOE—atherosclerosis	5.09e-06	0.000102	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CAV1—atherosclerosis	5.05e-06	0.000101	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOA1—atherosclerosis	5.03e-06	0.000101	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—atherosclerosis	4.88e-06	9.81e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.6e-06	9.24e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—atherosclerosis	4.5e-06	9.05e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—atherosclerosis	4.44e-06	8.92e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—INS—atherosclerosis	4.35e-06	8.75e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALB—atherosclerosis	3.99e-06	8.02e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NOS3—atherosclerosis	3.82e-06	7.67e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.49e-06	7.02e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—atherosclerosis	1.75e-06	3.53e-05	CbGpPWpGaD
